Physician

Manzurul A. Sikder, MD

According to 2025 Medicare claims, Manzurul Sikder, MD (NPI: 1598885741) practices hematology/oncology in the Utica-Rome, NY market, with the plurality of this provider's patient population coming from Oneida, NY. This provider's primary affiliated billing organization is SLOCUM DICKSON MEDICAL GROUP PLLC (NPI: 1285625996; TIN: 200362623) and primary practice location at 13413-1001. Sikder is affiliated with the Bassett Accountable Care Partners, LLC (ACO ID: A2612), Trinity Health Integrated Care (ACO ID: A3454), Caravan Health ACO 50 LLC (ACO ID: A5160), and Main Street Rural Health Willow ACO LLC (ACO ID: A5404), participating under the MSSP model.

Sikder's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 736 traditional Medicare patients, billed 241,589 HCPCS/CPT codes, and received $3,344,713 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 1,084 prescription claims across 270 beneficiaries totaling $2,551,960 in drug costs, led by Revlimid (Lenalidomide). 2023 DME data shows 60 claims. Open Payments data shows 18 records totaling $3,229. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $2,756,154 and ending at $3,344,713. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $1,332,878 to $2,551,960. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $7,223 to $0.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	621	258,063	$2,756,154
2016	692	267,421	$3,136,378
2017	728	331,496	$3,370,893
2018	752	270,763	$2,645,340
2019	652	248,094	$2,441,400
2020	595	159,601	$1,813,506
2021	560	173,254	$1,447,416
2022	711	339,534	$3,667,064
2023	736	368,174	$5,075,394
2024	736	241,589	$3,344,713

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	196	1,057	$1,332,878
2016	203	881	$1,224,418
2017	205	794	$984,408
2018	190	593	$749,117
2019	164	509	$669,054
2020	132	369	$431,891
2021	152	425	$373,558
2022	264	1,089	$2,694,101
2023	290	1,515	$3,318,957
2024	270	1,084	$2,551,960

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	24	214	$4,983
2016	20	200	$4,593
2017	21	257	$5,164
2018	14	111	$663
2019	19	93	$841
2020	14	33	$7
2021	N/R	11	$2,194
2022	N/R	37	$725
2023	N/R	60	$2,360
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	184	279	$120
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	558	1,969	$91
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	449	876	$12
96372	Injection of drug or substance under skin or into muscle	230	1,227	$10
J3420	Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg	115	515	$1

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Revlimid	Lenalidomide	41	1,057	$639,463
Lenalidomide	Lenalidomide	39	1,092	$593,433
Xtandi	Enzalutamide	18	540	$249,285
Ibrance	Palbociclib	16	371	$196,339
Xarelto	Rivaroxaban	125	8,498	$146,527

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	18	$3,229	E.R. Squibb & Sons, L.L.C.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Manzurul A. Sikder, MD?

Tedicare shows public-source Medicare data for Manzurul A. Sikder, MD (NPI 1598885741), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Manzurul A. Sikder, MD have ACO affiliation data?

Manzurul A. Sikder, MD is shown with ACO affiliation data for Bassett Accountable Care Partners, LLC (MSSP, ACO ID A2612), Trinity Health Integrated Care (MSSP, ACO ID A3454), Caravan Health ACO 50 LLC (MSSP, ACO ID A5160), and Main Street Rural Health Willow ACO LLC (MSSP, ACO ID A5404).

What billing organization is linked to Manzurul A. Sikder, MD?

Manzurul A. Sikder, MD is linked to SLOCUM DICKSON MEDICAL GROUP PLLC (billing NPI 1285625996) in the available physician profile data.

Does Manzurul A. Sikder, MD have Open Payments data?

Manzurul A. Sikder, MD has 18 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.